Coronavirus | Bangladesh gifts India 10,000 Remdesivir vials

The doses of Remdesivir were produced by Beximco, one of the biggest pharmaceutical companies of Bangladesh.

May 06, 2021 06:56 pm | Updated 06:57 pm IST - NEW DELHI

Remdesivir antiviral injectable drug.

Remdesivir antiviral injectable drug.

Bangladesh on Thursday handed over 10,000 vials of Remdesivir injection to an Indian government representative. The consignment of Remdesivir that is used for treating serious patients of COVID-19 infection was handed over by the Bangladesh Deputy High Commissioner in Kolkata at the Indian border port of Petrapole, a press release from the Government of Bangladesh said.

The supply of the medicine took place days after the Ministry of External Affairs announced that India had been offered essential drugs and other necessary items by Dhaka to fight the second wave of the COVID-19 pandemic. This is a part of the ongoing international mobilisation to help India overcome the spike in the infection.

The doses of Remdesivir were produced by Beximco, one of the biggest pharmaceutical companies of Bangladesh, which also partners the Serum Institute of India to provide Covishield vaccine to Bangladesh. A press release from the Government of Bangladesh infomed that the consignment was sent to India following an instruction from Prime Minister Sheikh Hasina.

This was the first part of the medical assistance from Bangladesh for COVID-hit India. This is likely to be followed by a large number of Vitamin C, D, Zinc supplements, N95 masks and possibly other critically needed medicines for the treatment of the COVID-19 affected.

Bangladesh is also dealing with COVID-19 and witnessed 41 deaths during Thursday. Available estimates suggest that cases are declining in the country.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.